세계의 동정맥기형 시장 보고서(2025년)

Arteriovenous malformations are abnormal tangles of blood vessels that form direct connections between arteries and veins, bypassing the normal capillary system. This disruption affects normal blood flow and oxygen circulation, potentially leading to complications. Early diagnosis and appropriate treatment are essential for managing symptoms and reducing the risk of severe complications.

The primary types of arteriovenous malformations include true arteriovenous malformation, occult or cryptic malformations, cavernous malformations, venous malformations, hemangiomas, dural fistulas, and others. True arteriovenous malformation is a congenital vascular anomaly characterized by a direct connection between arteries and veins, bypassing the capillary system. Diagnosis methods include physical examinations, brain scans, and other imaging techniques. Treatment options consist of endovascular embolization and neurosurgery, catering to different age groups such as adult and pediatric patients. These treatments are utilized across various end-users, including hospitals and clinics, research laboratories, and others.

The arteriovenous malformations market research report is one of a series of new reports from The Business Research Company that provides arteriovenous malformations market statistics, including arteriovenous malformations industry global market size, regional shares, competitors with a arteriovenous malformations market share, detailed arteriovenous malformations market segments, market trends and opportunities, and any further data you may need to thrive in the arteriovenous malformations industry. These arteriovenous malformations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The arteriovenous malformations market size has grown strongly in recent years. It will grow from $2.88 billion in 2024 to $3.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth during the historic period can be attributed to the rising prevalence of arteriovenous malformations, the increasing occurrence of neurological and brain disorders, the growing need for improved treatments for rare diseases, enhanced government support for research and development, and the expansion of the business sector.

The arteriovenous malformations market size is expected to see strong growth in the next few years. It will grow to $4.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The projected growth during the forecast period can be attributed to the increasing use of gene therapy, the rising demand for advanced medical technology, the growing need for quality healthcare, the increasing consumption of neurological drugs, and the expansion of the aging population. Key trends expected during this period include advancements in treatment options, innovations in medical technology, progress in microsurgical techniques, developments in catheter technology, and improvements in minimally invasive surgical procedures.

The growing demand for minimally invasive procedures is expected to drive the expansion of the arteriovenous malformations (AVMs) market. Minimally invasive procedures involve surgical or therapeutic interventions that use small incisions or catheter-based techniques to minimize trauma, reduce recovery time, and lower the risk of complications. These procedures are increasingly popular because they enable faster recovery, as smaller incisions cause less tissue damage and shorten healing times. This allows patients to return to their daily routines more quickly compared to traditional open surgeries, making them a preferred choice for both patients and healthcare providers. Arteriovenous malformations are treated using advanced techniques such as endovascular embolization, where catheters and image-guided procedures are employed to reduce abnormal blood flow without the need for open surgery. This approach leads to lower risks, quicker recovery, and improved patient outcomes. For example, in September 2023, the American Society of Plastic Surgeons reported that 25,442,640 cosmetic minimally invasive procedures were performed in 2023, reflecting a 7% increase from the 23,672,269 procedures in 2022. This growth highlights the rising preference for minimally invasive treatments and contributes to the growth of the AVMs market.

Increasing investment in biotechnology is also expected to drive the growth of the arteriovenous malformations market. Biotechnology involves the use of biological processes, organisms, or systems to develop healthcare-related products and technologies. Investment in biotechnology has surged due to breakthroughs in gene editing technologies such as CRISPR, which enable precise genetic modifications and medical innovations. Arteriovenous malformations contribute to biotechnology by improving medical imaging, gene therapy, and minimally invasive treatments, leading to the development of biotechnology-based solutions such as targeted drug delivery, biomaterials for vascular repair, and AI-assisted diagnostics. In August 2024, The BioIndustry Association (BIA) reported that the UK's life sciences and biotechnology sector secured $2.55 billion in investment during the first two quarters of 2024, surpassing the $2.32 billion raised in 2023. This increase in biotechnology investment is helping to drive the growth of the AVMs market.

Companies in the arteriovenous malformations market are also focusing on technological advancements, such as liquid embolic system procedural sets, to enhance treatment procedures and improve patient outcomes. A liquid embolic system procedural set is a pre-assembled, sterilized kit that contains the essential components needed to deliver liquid embolic agents to treat vascular abnormalities such as AVMs. For instance, in March 2024, CERENOVUS Inc., a US-based neurovascular care company under Johnson and Johnson MedTech, introduced the TRUFILL n-BCA liquid embolic system procedural set. This new set includes two configurations and all necessary accessories for preparing and delivering the n-BCA liquid embolic system in a single sterilized package, making procedure preparation more efficient for treating cerebral AVMs.

Major players in the arteriovenous malformations market are Johnson And Johnson Services Inc., Siemens AG, Medtronic Plc, Koninklijke Philips N V, Stryker Corporation, GE Healthcare Technologies Inc, Cedars-Sinai, Penn Medicine, Terumo Corporation, Eisai Co Ltd, Cook Medical LLC, Elekta AB, Merit Medical Systems Inc., Penumbra Inc., Max Healthcare, RWJBarnabas Health, Balt LLC, Booking Health GmbH, Duke University Health System, Shape Memory Medical Inc.

North America was the largest region in the arteriovenous malformations market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in arteriovenous malformations report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the arteriovenous malformations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The arteriovenous malformations market consists of revenues earned by entities by providing services such as minimally invasive embolization, post-procedure rehabilitation, and telemedicine consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The arteriovenous malformations market also includes sales of embolization devices, neurovascular catheters, liquid embolic agents, microsurgical instruments, and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Arteriovenous Malformations Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on arteriovenous malformations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for arteriovenous malformations ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The arteriovenous malformations market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: True Arteriovenous Malformation; Occult Or Cryptic; Cavernous Malformations; Venous Malformation; Hemangioma; Dural Fistula; Other Types
• 2) By Diagnosis: Physical examination; Brain Scans; Other Diagnosis
• 3) By Treatment: Endovascular Embolization; Neurosurgery
• 4) By Age Group: Adult Patients; Pediatric Patients
• 5) By End-User: Hospitals And Clinics; Research laboratories; Other End-Users
• Sub Segments:
• 1) By True Arteriovenous Malformation Type: Pial AVMs; Spinal AVMs; Brain AVMs; Extremity AVMs; Visceral AVMs
• 2) By Occult or Cryptic Type: Micro-AVMs; Hidden AVMs; Asymptomatic AVMs; Deep-Seated AVMs; Small-Scale AVMs
• 3) By Cavernous Malformations Type: Cerebral Cavernous Malformations (CCMs); Spinal Cavernous Malformations; Familial Cavernous Malformations; Solitary Cavernous Malformations; Multiple Cavernous Malformations
• 4) By Venous Malformation Type: Superficial Venous Malformations; Deep Venous Malformations; Mixed Venous Malformations; Syndromic Venous Malformations; Blue Rubber Bleb Nevus Syndrome
• 5) By Hemangioma Type: Infantile Hemangiomas; Capillary Hemangiomas; Lobular Capillary Hemangiomas; Cavernous Hemangiomas; Compound Hemangiomas
• 6) By Dural Fistula Type: Cranial Dural Arteriovenous Fistula (dAVF); Spinal Dural Arteriovenous Fistula; Direct Dural AV Fistula; Indirect Dural AV Fistula; High-Flow Dural Fistula
• 7) By Other Types: Lymphatic Malformations; Mixed Vascular Malformations; Arteriovenous Aneurysms; Hereditary Hemorrhagic Telangiectasia (HHT)-Associated AVMs; Rare Congenital AVMs
• Companies Mentioned: Johnson And Johnson Services Inc.; Siemens AG; Medtronic Plc; Koninklijke Philips N V; Stryker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Arteriovenous Malformations Market Characteristics

3. Arteriovenous Malformations Market Trends And Strategies

4. Arteriovenous Malformations Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Arteriovenous Malformations Growth Analysis And Strategic Analysis Framework

• 5.1. Global Arteriovenous Malformations PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Arteriovenous Malformations Market Growth Rate Analysis
• 5.4. Global Arteriovenous Malformations Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Arteriovenous Malformations Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Arteriovenous Malformations Total Addressable Market (TAM)

6. Arteriovenous Malformations Market Segmentation

• 6.1. Global Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• True Arteriovenous Malformation
• Occult Or Cryptic
• Cavernous Malformations
• Venous Malformation
• Hemangioma
• Dural Fistula
• Other Types
• 6.2. Global Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical examination
• Brain Scans
• Other Diagnosis
• 6.3. Global Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endovascular Embolization
• Neurosurgery
• 6.4. Global Arteriovenous Malformations Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adult Patients
• Pediatric Patients
• 6.5. Global Arteriovenous Malformations Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Research laboratories
• Other End-Users
• 6.6. Global Arteriovenous Malformations Market, Sub-Segmentation Of True Arteriovenous Malformation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pial AVMs
• Spinal AVMs
• Brain AVMs
• Extremity AVMs
• Visceral AVMs
• 6.7. Global Arteriovenous Malformations Market, Sub-Segmentation Of Occult or Cryptic Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Micro-AVMs
• Hidden AVMs
• Asymptomatic AVMs
• Deep-Seated AVMs
• Small-Scale AVMs
• 6.8. Global Arteriovenous Malformations Market, Sub-Segmentation Of Cavernous Malformations Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cerebral Cavernous Malformations (CCMs)
• Spinal Cavernous Malformations
• Familial Cavernous Malformations
• Solitary Cavernous Malformations
• Multiple Cavernous Malformations
• 6.9. Global Arteriovenous Malformations Market, Sub-Segmentation Of Venous Malformation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Superficial Venous Malformations
• Deep Venous Malformations
• Mixed Venous Malformations
• Syndromic Venous Malformations
• Blue Rubber Bleb Nevus Syndrome
• 6.10. Global Arteriovenous Malformations Market, Sub-Segmentation Of Hemangioma Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infantile Hemangiomas
• Capillary Hemangiomas
• Lobular Capillary Hemangiomas
• Cavernous Hemangiomas
• Compound Hemangiomas
• 6.11. Global Arteriovenous Malformations Market, Sub-Segmentation Of Dural Fistula Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cranial Dural Arteriovenous Fistula (dAVF)
• Spinal Dural Arteriovenous Fistula
• Direct Dural AV Fistula
• Indirect Dural AV Fistula
• High-Flow Dural Fistula
• 6.12. Global Arteriovenous Malformations Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lymphatic Malformations
• Mixed Vascular Malformations
• Arteriovenous Aneurysms
• Hereditary Hemorrhagic Telangiectasia (HHT)-Associated AVMs
• Rare Congenital AVMs

7. Arteriovenous Malformations Market Regional And Country Analysis

• 7.1. Global Arteriovenous Malformations Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Arteriovenous Malformations Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Arteriovenous Malformations Market

• 8.1. Asia-Pacific Arteriovenous Malformations Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Arteriovenous Malformations Market

• 9.1. China Arteriovenous Malformations Market Overview
• 9.2. China Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Arteriovenous Malformations Market

• 10.1. India Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Arteriovenous Malformations Market

• 11.1. Japan Arteriovenous Malformations Market Overview
• 11.2. Japan Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Arteriovenous Malformations Market

• 12.1. Australia Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Arteriovenous Malformations Market

• 13.1. Indonesia Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Arteriovenous Malformations Market

• 14.1. South Korea Arteriovenous Malformations Market Overview
• 14.2. South Korea Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Arteriovenous Malformations Market

• 15.1. Western Europe Arteriovenous Malformations Market Overview
• 15.2. Western Europe Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Arteriovenous Malformations Market

• 16.1. UK Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Arteriovenous Malformations Market

• 17.1. Germany Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Arteriovenous Malformations Market

• 18.1. France Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Arteriovenous Malformations Market

• 19.1. Italy Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Arteriovenous Malformations Market

• 20.1. Spain Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Arteriovenous Malformations Market

• 21.1. Eastern Europe Arteriovenous Malformations Market Overview
• 21.2. Eastern Europe Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Arteriovenous Malformations Market

• 22.1. Russia Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Arteriovenous Malformations Market

• 23.1. North America Arteriovenous Malformations Market Overview
• 23.2. North America Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Arteriovenous Malformations Market

• 24.1. USA Arteriovenous Malformations Market Overview
• 24.2. USA Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Arteriovenous Malformations Market

• 25.1. Canada Arteriovenous Malformations Market Overview
• 25.2. Canada Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Arteriovenous Malformations Market

• 26.1. South America Arteriovenous Malformations Market Overview
• 26.2. South America Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Arteriovenous Malformations Market

• 27.1. Brazil Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Arteriovenous Malformations Market

• 28.1. Middle East Arteriovenous Malformations Market Overview
• 28.2. Middle East Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Arteriovenous Malformations Market

• 29.1. Africa Arteriovenous Malformations Market Overview
• 29.2. Africa Arteriovenous Malformations Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Arteriovenous Malformations Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Arteriovenous Malformations Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Arteriovenous Malformations Market Competitive Landscape And Company Profiles

• 30.1. Arteriovenous Malformations Market Competitive Landscape
• 30.2. Arteriovenous Malformations Market Company Profiles
  • 30.2.1. Johnson And Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips N V Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Arteriovenous Malformations Market Other Major And Innovative Companies

• 31.1. GE Healthcare Technologies Inc
• 31.2. Cedars-Sinai
• 31.3. Penn Medicine
• 31.4. Terumo Corporation
• 31.5. Eisai Co Ltd
• 31.6. Cook Medical LLC
• 31.7. Elekta AB
• 31.8. Merit Medical Systems Inc.
• 31.9. Penumbra Inc.
• 31.10. Max Healthcare
• 31.11. RWJBarnabas Health
• 31.12. Balt LLC
• 31.13. Booking Health GmbH
• 31.14. Duke University Health System
• 31.15. Shape Memory Medical Inc.

32. Global Arteriovenous Malformations Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Arteriovenous Malformations Market

34. Recent Developments In The Arteriovenous Malformations Market

35. Arteriovenous Malformations Market High Potential Countries, Segments and Strategies

• 35.1 Arteriovenous Malformations Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Arteriovenous Malformations Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Arteriovenous Malformations Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer